# Thalassemia Treatment Based on the Stem Cell Technology

> **NCT03222453** · NA · UNKNOWN · sponsor: **Xiaofang Sun** · enrollment: 2 (actual)

## Conditions studied

- Beta-Thalassemia

## Interventions

- **BIOLOGICAL:** Hematopoetic stem cells

## Key facts

- **NCT ID:** NCT03222453
- **Lead sponsor:** Xiaofang Sun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-01
- **Primary completion:** 2016-06-14
- **Final completion:** 2017-12-31
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222453, "Thalassemia Treatment Based on the Stem Cell Technology". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03222453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*